Brigham and Women's Hospital Diabetes Program — Boston, Massachusetts

Brigham and Women's Hospital Diabetes Program is a clinical research site located in Boston, Massachusetts, United States 02115.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Brigham and Women's Hospital Diabetes Program has participated in 7 clinical trials with 6 currently active.

Therapeutic areas: Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Type 2 Diabetes Mellitus.

Sponsors: Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Brigham and Women's Hospital Diabetes Program?

Brigham and Women's Hospital Diabetes Program has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Brigham and Women's Hospital Diabetes Program conducted?

Brigham and Women's Hospital Diabetes Program has 7 clinical trials on record, with 6 currently active. Their work covers Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Type 2 Diabetes Mellitus.

Is Brigham and Women's Hospital Diabetes Program accredited by Crixeo Health?

Brigham and Women's Hospital Diabetes Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Brigham and Women's Hospital Diabetes Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.